Home LiteratureArticle Details
PMID: 21098716 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.

Cancer research ·Vol. 70 ·No. 23 ·2010-12-01 ·Pages 9969-78

Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, Wicha MS, Nör JE

Abstract

Recent studies have demonstrated that cancer stem cells play an important role in the pathobiology of head and neck squamous cell carcinomas (HNSCC). However, little is known about functional interactions between head and neck cancer stem-like cells (CSC) and surrounding stromal cells. Here, we used aldehyde dehydrogenase activity and CD44 expression to sort putative stem cells from primary human HNSCC. Implantation of 1,000 CSC (ALDH+CD44+Lin-) led to tumors in 13 (out of 15) mice, whereas 10,000 noncancer stem cells (ALDH-CD44-Lin-) resulted in 2 tumors in 15 mice. These data demonstrated that ALDH and CD44 select a subpopulation of cells that are highly tumorigenic. The ability to self-renew was confirmed by the observation that ALDH+CD44+Lin- cells sorted from human HNSCC formed more spheroids (orospheres) in 3-D agarose matrices or ultra-low attachment plates than controls and were serially passaged in vivo. We observed that approximately 80% of the CSC were located in close proximity (within 100-μm radius) of blood vessels in human tumors, suggesting the existence of perivascular niches in HNSCC. In vitro studies demonstrated that endothelial cell-secreted factors promoted self-renewal of CSC, as demonstrated by the upregulation of Bmi-1 expression and the increase in the number of orospheres as compared with controls. Notably, selective ablation of tumor-associated endothelial cells stably transduced with a caspase-based artificial death switch (iCaspase-9) caused a marked reduction in the fraction of CSC in xenograft tumors. Collectively, these findings indicate that endothelial cell-initiated signaling can enhance the survival and self-renewal of head and neck CSC.

MeSH Terms
Aldehyde Dehydrogenase/metabolism Animals Apoptosis/drug effects Carcinoma, Squamous Cell/blood supply,metabolism,pathology Cell Line, Tumor Cell Proliferation Cell Survival Cells, Cultured Endothelial Cells/metabolism Head and Neck Neoplasms/blood supply,metabolism,pathology Humans Hyaluronan Receptors/metabolism Immunohistochemistry Isoenzymes/metabolism Mice Mice, SCID Microscopy, Confocal Neoplasms, Experimental/blood supply,metabolism,pathology Neoplastic Stem Cells/metabolism Neovascularization, Pathologic Signal Transduction Tacrolimus/analogs & derivatives,pharmacology Transplantation, Heterologous
Chemicals
AP20187 Hyaluronan Receptors Isoenzymes Aldehyde Dehydrogenase Tacrolimus
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Krishnamurthy Sudha
Angiogenesis Research Laboratory, University of Michigan, Ann Arbor, Michigan, USA.
Dong Zhihong
Vodopyanov Dmitry
Imai Atsushi
Helman Joseph I
Prince Mark E
Wicha Max S
Nör Jacques E
References (35)
35 references, click to expand
  1. Stem cells and their niches.
    Science. 2006 Mar 31;311(5769):1880-5 PMID: 16574858
  2. Ablation of microvessels in vivo upon dimerization of iCaspase-9.
    Gene Ther. 2002 Apr;9(7):444-51 PMID: 11938459
  3. Level of endothelial cell apoptosis required for a significant decrease in microvessel density.
    Exp Cell Res. 2007 Oct 1;313(16):3645-57 PMID: 17720154
  4. Socializing with the neighbors: stem cells and their niche.
    Cell. 2004 Mar 19;116(6):769-78 PMID: 15035980
  5. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity.
    Stem Cells. 2006 Apr;24(4):975-85 PMID: 16293577
  6. Prospective identification of tumorigenic breast cancer cells.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 PMID: 12629218
  7. Cancer stem cells: mirage or reality?
    Nat Med. 2009 Sep;15(9):1010-2 PMID: 19734877
  8. Recent advances in cancer stem cells.
    Curr Opin Genet Dev. 2008 Feb;18(1):48-53 PMID: 18356041
  9. Targeting stem cells-clinical implications for cancer therapy.
    Curr Stem Cell Res Ther. 2009 May;4(2):147-53 PMID: 19442199
  10. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.
    Biochem Biophys Res Commun. 2009 Jul 31;385(3):307-13 PMID: 19450560
  11. The cancer stem cell-vascular niche complex in brain tumor formation.
    Stem Cells Dev. 2008 Oct;17(5):859-67 PMID: 18429673
  12. Stem cells, cancer, and cancer stem cells.
    Nature. 2001 Nov 1;414(6859):105-11 PMID: 11689955
  13. Heterogeneity in cancer: cancer stem cells versus clonal evolution.
    Cell. 2009 Sep 4;138(5):822-9 PMID: 19737509
  14. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.
    Genes Dev. 2003 May 15;17(10):1253-70 PMID: 12756227
  15. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Cancer Res. 2007 Apr 15;67(8):3560-4 PMID: 17440065
  16. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
    Oral Oncol. 2009 Jul;45(7):633-9 PMID: 19027347
  17. A perivascular niche for brain tumor stem cells.
    Cancer Cell. 2007 Jan;11(1):69-82 PMID: 17222791
  18. Cancer stem cells, hypoxia and metastasis.
    Semin Radiat Oncol. 2009 Apr;19(2):106-11 PMID: 19249648
  19. Cancer stem cells persist in many cancer cell lines.
    Cell Cycle. 2004 Apr;3(4):414-5 PMID: 15004528
  20. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
    Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8 PMID: 17210912
  21. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
    Cell Stem Cell. 2007 Nov;1(5):555-67 PMID: 18371393
  22. Metastasis of squamous cell carcinoma of the oral tongue.
    Cancer Metastasis Rev. 2007 Dec;26(3-4):645-62 PMID: 17768600
  23. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche.
    Cell. 2004 Sep 3;118(5):635-48 PMID: 15339667
  24. Chemotherapy in the treatment of locally advanced head and neck cancer.
    J Surg Oncol. 2008 Jun 15;97(8):701-7 PMID: 18493921
  25. Cancer stem cells in solid tumors.
    Semin Cancer Biol. 2010 Apr;20(2):77-84 PMID: 20371287
  26. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells.
    Science. 2004 May 28;304(5675):1338-40 PMID: 15060285
  27. Engineering and characterization of functional human microvessels in immunodeficient mice.
    Lab Invest. 2001 Apr;81(4):453-63 PMID: 11304564
  28. Head and neck cancer: past, present and future.
    Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8 PMID: 16831082
  29. Neck disease and distant metastases.
    Oral Oncol. 2003 Apr;39(3):207-12 PMID: 12618192
  30. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1537-49 PMID: 12459383
  31. Identification of pancreatic cancer stem cells.
    Cancer Res. 2007 Feb 1;67(3):1030-7 PMID: 17283135
  32. The biology of cancer stem cells.
    Annu Rev Cell Dev Biol. 2007;23:675-99 PMID: 17645413
  33. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions.
    Cell Stem Cell. 2008 Sep 11;3(3):289-300 PMID: 18786416
  34. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.
    Immunity. 2006 Dec;25(6):977-88 PMID: 17174120
  35. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
    Cancer Res. 2009 Apr 15;69(8):3382-9 PMID: 19336570
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
1538-7445
Published
2010-12-01
Epub
2010-00-23
Pages
9969-78
Language
English
Region
United States
NLM ID
2984705R
PMCID
PMC3058885
Subset
IM
Grants
NCI NIH HHS · P50 CA097248 · United States
NIDCR NIH HHS · R21 DE019279 · United States
NIDCR NIH HHS · R01-DE15948 · United States
NCI NIH HHS · P50-CA97248 · United States
NIDCR NIH HHS · R01 DE014601 · United States
NIDCR NIH HHS · R01 DE016586-01 · United States
NIDCR NIH HHS · R01-DE14601 · United States
NIDCR NIH HHS · R01 DE016586 · United States
NIDCR NIH HHS · R21 DE019279-01 · United States
NIDCR NIH HHS · R01 DE015948-01 · United States
NIDCR NIH HHS · R01-DE16586 · United States
NIDCR NIH HHS · R01 DE015948 · United States
NCI NIH HHS · P50 CA097248-080006 · United States
NIDCR NIH HHS · R21-DE19279 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com